PowerShares Dynamic Retail ETF (PMR)
NYSEArca - NYSEArca Delayed Price. Currency in USD
- PR Newswire•3 days ago
PharmaMar (PHM.V) has announced today the submission to the European Medicines Agency (EMA) of the Marketing Authorization Application (MAA) for Aplidin® (plitidepsin) in combination with dexamethasone for the treatment of relapsed/refractory multiple myeloma (MM). This is a type of blood cancer which represents 10% of all hematological malignancies. PharmaMar has gone through with this application given the positive data obtained from the randomized, Phase III ADMYRE clinical trial, where the efficacy and safety of Aplidin® with dexamethasone versus dexamethasone alone in patients with relapsed/refractory MM after at least three, but no more than six, prior therapeutic regimens has been evaluated.
- MarketWatch•5 days ago
A number of brick-and-mortar stores have announced store closures in 2016, but an ETF tracking the e-commerce space has seen sharp gains since being launched in April.